You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
Register for free to read this article
As a service to the community, this article is available for free. Existing users log in.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Dendritic cell migration reform
Dendritic cells are the messengers of the immune system, transporting antigens from sites of inflammation to the lymph organs that serve as central hubs for immune activation. Ufer et al. have identified a neuronal plasticity molecule—activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1)—that is expressed in migratory dendritic cells in the skin. Arc/Arg3.1 regulates cytoskeletal changes in dendritic cells, accelerating migration in response to inflammation. Moreover, Arc/Arg3.1 was required for inducing T cell responses in two different disease models—experimental autoimmune encephalitis and allergic contact dermatitis. Targeting Arc/Arg3.1 may therefore be a therapeutic strategy to modify dendritic cell immunotherapy.
- Copyright © 2016, American Association for the Advancement of Science